Adult patients with biopsy-proven adenocarcinoma prior to receiving any therapy such as surgery, radiation or chemotherapy.

Patients without pancreas cancer.

Adult patients with benign pancreas disorders such as pancreatitis with imaging within 12 months (CT, MRI, EUS) documenting no cancer.

Healthy adults with blood specimens in an existing biobank.

Patients with pancreatic cystic lesions.

Adult patients undergoing clinically indicated EUS-guided FNA biopsy of pancreatic cystic lesions.

ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer